Arch Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Arch Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2011 to Q2 2024.
  • Arch Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.65M, a 210% decline year-over-year.
  • Arch Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$12.3M, a 91.2% decline year-over-year.
  • Arch Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$6.98M, a 32.4% decline from 2022.
  • Arch Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.28M, a 15.5% increase from 2021.
  • Arch Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.24M, a 33% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$12.3M -$5.65M -$3.83M -210% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$8.43M -$1.47M -$567K -62.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-19
Q4 2023 -$7.86M -$2.68M -$882K -49% Oct 1, 2023 Dec 31, 2023 10-Q 2024-08-19
Q3 2023 -$6.98M -$2.46M -$569K -30.1% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-15
Q2 2023 -$6.41M -$1.82M -$776K -74.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$5.64M -$902K -$112K -14.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-19
Q4 2022 -$5.53M -$1.8M -$250K -16.1% Oct 1, 2022 Dec 31, 2022 10-Q 2024-08-19
Q3 2022 -$5.28M -$1.89M -$123K -6.99% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-15
Q2 2022 -$5.15M -$1.05M +$483K +31.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$5.64M -$790K +$1M +55.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q4 2021 -$6.64M -$1.55M -$396K -34.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$6.24M -$1.77M -$370K -26.5% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-28
Q2 2021 -$5.87M -$1.53M -$626K -69.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$5.25M -$1.79M -$1.06M -145% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$4.19M -$1.15M +$506K +30.5% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 -$4.69M -$1.4M -$567K -68.5% Jul 1, 2020 Sep 30, 2020 10-K 2020-12-11
Q2 2020 -$4.12M -$904K +$385K +29.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$4.51M -$732K -$902K -531% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.61M -$1.66M +$940K +36.2% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 -$4.55M -$828K +$607K +42.3% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-11
Q2 2019 -$5.15M -$1.29M +$923K +41.7% Apr 1, 2019 Jun 30, 2019 10-K 2020-12-11
Q1 2019 -$6.08M $170K +$1.73M Jan 1, 2019 Mar 31, 2019 10-K 2020-12-11
Q4 2018 -$7.8M -$2.6M -$2.99M -768% Oct 1, 2018 Dec 31, 2018 10-K 2020-12-11
Q3 2018 -$4.81M -$1.44M +$1.31M +47.7% Jul 1, 2018 Sep 30, 2018 10-K 2019-11-19
Q2 2018 -$6.12M -$2.21M -$437K -24.6% Apr 1, 2018 Jun 30, 2018 10-K 2019-11-19
Q1 2018 -$5.68M -$1.56M +$314K +16.8% Jan 1, 2018 Mar 31, 2018 10-K 2019-11-19
Q4 2017 -$6M $389K +$1.79M Oct 1, 2017 Dec 31, 2017 10-K 2019-11-19
Q3 2017 -$7.79M -$2.74M -$925K -50.9% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-18
Q2 2017 -$6.86M -$1.78M -$9.96K -0.56% Apr 1, 2017 Jun 30, 2017 10-K 2018-12-18
Q1 2017 -$6.85M -$1.87M -$616K -49.2% Jan 1, 2017 Mar 31, 2017 10-K 2018-12-18
Q4 2016 -$6.24M -$1.4M -$245K -21.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-12-18
Q3 2016 -$5.99M -$1.82M -$96.6K -5.61% Jul 1, 2016 Sep 30, 2016 10-K 2017-11-15
Q2 2016 -$5.9M -$1.77M -$993K -129% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 -$4.9M -$1.25M -$419K -50.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$4.48M -$1.16M -$1.54M -405% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-01
Q3 2015 -$2.95M -$1.72M -$2.36M -371% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-05
Q2 2015 -$592K -$772K -$1.18M -288% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $591K -$834K +$7.55M +90% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 -$6.96M $379K +$1.19M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-12
Q3 2014 -$8.14M $635K +$1.6M Jul 1, 2014 Sep 30, 2014 10-K 2015-12-11
Q2 2014 -$9.74M $411K +$925K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$10.7M -$8.38M -$8.21M -4753% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$2.46M -$808K -$603K -294% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 -$1.85M -$962K -$572K -147% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-12
Q2 2013 -$1.28M -$514K -$338K -191% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$945K -$173K -$164K -1796% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$781K -$205K -$204K Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$577K -$390K Jul 1, 2012 Sep 30, 2012 10-K/A 2014-05-01
Q2 2012 -$177K -$177K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$9.11K -$9.11K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 -$868* Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q2 2011 -$19* Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.